Your browser doesn't support javascript.
loading
Structural determination and kinetic analysis of the transketolase from Vibrio vulnificus reveal unexpected cooperative behavior.
Georges, Rainier-Numa; Ballut, Lionel; Octobre, Guillaume; Comte, Arnaud; Hecquet, Laurence; Charmantray, Franck; Doumèche, Bastien.
Afiliación
  • Georges RN; Univ Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Ballut L; Molecular Microbiology and Structural Biochemistry, UMR 5086, CNRS-Université de Lyon, Lyon, France.
  • Octobre G; Univ Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Comte A; Univ Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Hecquet L; Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut de Chimie de Clermont-Ferrand (ICCF), Clermont-Ferrand, France.
  • Charmantray F; Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut de Chimie de Clermont-Ferrand (ICCF), Clermont-Ferrand, France.
  • Doumèche B; Univ Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
Protein Sci ; 33(3): e4884, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38145310
ABSTRACT
Vibrio vulnificus (vv) is a multidrug-resistant human bacterial pathogen whose prevalence is expected to increase over the years. Transketolases (TK), transferases catalyzing two reactions of the nonoxidative branch of the pentose-phosphate pathway and therefore linked to several crucial metabolic pathways, are potential targets for new drugs against this pathogen. Here, the vvTK is crystallized and its structure is solved at 2.1 Å. A crown of 6 histidyl residues is observed in the active site and expected to participate in the thiamine pyrophosphate (cofactor) activation. Docking of fructose-6-phosphate and ferricyanide used in the activity assay, suggests that both substrates can bind vvTK simultaneously. This is confirmed by steady-state kinetics showing a sequential mechanism, on the contrary to the natural transferase reaction which follows a substituted mechanism. Inhibition by the I38-49 inhibitor (2-(4-ethoxyphenyl)-1-(pyrimidin-2-yl)-1H-pyrrolo[2,3-b]pyridine) reveals for the first time a cooperative behavior of a TK and docking experiments suggest a previously undescribed binding site at the interface between the pyrophosphate and pyridinium domains.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcetolasa / Vibrio vulnificus Límite: Humans Idioma: En Revista: Protein Sci Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Transcetolasa / Vibrio vulnificus Límite: Humans Idioma: En Revista: Protein Sci Asunto de la revista: BIOQUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos